Vazalore
FDA Label NDC 73089-325

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Plx Pharma Inc for the product Vazalore (NDC 73089-325). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient, ask a doctor, ask a doctor or a pharmacist, otc - do not use, keet out of reach of children, oregnancy or breastfeeding, otc - purpose, otc - questions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.